NY grapples with cost of life-saving Hepatitis C drug
Capital New York - 9 hours ago
ALBANY—A new drug with a greater than 90-percent success rate for
curing Hepatitis C is on the market, but the state may not be able to
cover its cost for tens of thousands of people who don't have private
insurance. Sovaldi, manufactured by Gilead ...
...
ALBANY—A new drug with a greater than 90-percent success rate for
curing Hepatitis C is on the market, but the state may not be able to
cover its cost for tens of thousands of people who don't have private
insurance.
Sovaldi, manufactured by Gilead Sciences, was approved by the federal Food and Drug Administration in December 2013. It costs $1,000 per pill, and a 12-week standard course of treatment—one pill a day—costs $84,000.
Many of those who would be treated with the drug won’t be covered by private insurance. More than half the estimated 3.2 million people infected with Hepatitis C nationwide—including prisoners, veterans, the uninsured or Medicaid recipients—have their health coverage at least partially subsidized by taxpayers. ...
The Republican Healthcare Plan is the same as the Nazi Healthcare Plan for Old Jews...
Sovaldi, manufactured by Gilead Sciences, was approved by the federal Food and Drug Administration in December 2013. It costs $1,000 per pill, and a 12-week standard course of treatment—one pill a day—costs $84,000.
Many of those who would be treated with the drug won’t be covered by private insurance. More than half the estimated 3.2 million people infected with Hepatitis C nationwide—including prisoners, veterans, the uninsured or Medicaid recipients—have their health coverage at least partially subsidized by taxpayers. ...
No comments:
Post a Comment